-+ 0.00%
-+ 0.00%
-+ 0.00%

Immunome: Q4 Earnings Insights

Benzinga·03/03/2026 21:46:08
Listen to the news

Immunome (NASDAQ:IMNM) reported its Q4 earnings results on Tuesday, March 3, 2026 at 04:02 PM.

Here's what investors need to know about the announcement.

Earnings

Immunome missed estimated earnings by -25.0%, reporting an EPS of $-0.75 versus an estimate of $-0.6.

Revenue was down $2.74 million from the same period last year.

Previous Earnings Records

In the previous quarter, the company missed on EPS by $0.1, resulting in a 1.68% drop change in the share price the following day.

Here's a look at Immunome's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.55 -0.51 -0.57 -0.72
EPS Actual -0.65 -0.50 -0.52 -1.28
Revenue Estimate 727K 1.60M 457K 3.07M
Revenue Actual 0 4.01M 2.93M 2.74M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Immunome visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.